| Project/Area Number |
15K21111
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Urology
Experimental pathology
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | 腫瘍学 / 遺伝性疾患 / がん抑制遺伝子 / VHL / 褐色細胞腫 |
|---|
| Outline of Final Research Achievements |
Von Hippel-Lindau（VHL）disease is inherited cancer syndrome, which develop several types of cancers and/or is complicated by them. The aim of this project is to establish novel disease model of human VHL disease, and to elucidate the mechanism of the onset and/or the development of VHL disease using patient-derived iPS cells.
We developed the in vivo evaluation system to recapitulate VHL-associated cancers using NOD/SCID mice and new in vitro experimental method of the differentiation from iPS cells to the origins of VHL-associated cancers that there are no human cell lines. In addition, we selected some candidate target genes as useful for facilitating the differentiation to the origins of VHL-associated cancers.
These results suggested that in vivo and in vitro experimental methods as a basis for this project were established and we progressed forward the elucidation of the mechanism of the onset and/or the development of VHL disease.
|
